Since multiple AMLs that develop in TSC are due to independent second-hit mutations in TSC1 or TSC2 that occur in different progenitor cells12, it is possible that a PTC affects the susceptibility of patients to somatic mutations. This evidence concerns the gene TSC2 and tuberous sclerosis.